Richard B Stead Selected Research

hematide

11/2009	A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia.
8/2007	Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
9/2006	Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard B Stead Research Topics

Disease

3	Neoplasms (Cancer) 01/2020 - 09/2006
3	Anemia 11/2009 - 09/2006
3	Chronic Renal Insufficiency 11/2009 - 09/2006
2	Pure Red-Cell Aplasia 11/2009 - 08/2007
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Body Weight (Weight, Body) 11/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2006
1	Thrombocytopenia (Thrombopenia) 01/2003

Drug/Important Bio-Agent (IBA)

3	hematideIBA 11/2009 - 09/2006
3	Peptides (Polypeptides)IBA 11/2009 - 09/2006
2	AntibodiesIBA 11/2009 - 08/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	VaccinesIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 11/2009
1	Erythropoietin FDA Link 08/2007
1	HematinicsIBA 08/2007
1	polyethylene glycol-recombinant human megakaryocyte growth and development factor (PEG-MGDF)IBA 01/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2020
1	Subcutaneous Injections 11/2009